![](/img/cover-not-exists.png)
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer
Hortobagyi, G N, Stemmer, S M, Burris, H A, Yap, Y S, Sonke, G S, Paluch-Shimon, S, Campone, M, Petrakova, K, Blackwell, K L, Winer, E P, Janni, W, Verma, S, Conte, P, Arteaga, C L, Cameron, D A, MondLanguage:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz215
Date:
August, 2019
File:
PDF, 73 KB
english, 2019